Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Novus Biologicals™ Recombinant Human Nicotinic Acetylcholine R alpha 3/CHRNA3 His Protein
SDP

Catalog No. p-7105008 Shop All Novus Biologicals Products
Click to view available options
Quantity:
0.1 mg
0.5 mg

Highly purified. Generating reliable and reproducible results. Applications: SDS-Page

A denatured recombinant protein with a N-Terminal His-tag and corresponding to the amino acids 32-240 of Human Nicotinic Acetylcholine R alpha 3/CHRNA3 The Recombinant Human Nicotinic Acetylcholine R alpha 3/CHRNA3 Protein is derived from E. coli. The Recombinant Human Nicotinic Acetylcholine R alpha 3/CHRNA3 Protein has been validated for the following applications: SDS-Page.

Specifications

Concentration 1mg/mL
For Use With (Application) SDS-PAGE
Formulation 20mM Tris-HCl buffer(pH8.0) containing 10% glycerol
Gene ID (Entrez) 1136
Molecular Weight (g/mol) TMW: 27kDa
Quantity 0.1 mg
Storage Requirements Store at 4°C short term. Aliquot and store at −20°C long term. Avoid freeze-thaw cycles.
Gene Alias cholinergic receptor, nicotinic, alpha 3, cholinergic receptor, nicotinic, alpha polypeptide 3, LNCR2, MGC104879, NACHRA3, neuronal acetylcholine receptor subunit alpha-3, neuronal nicotinic acetylcholine receptor, alpha3 subunit, PAOD2
Common Name Nicotinic Acetylcholine R alpha 3/CHRNA3
Conjugate Unconjugated
Recombinant Recombinant
Purity or Quality Grade >80%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie™ Blue stain
Show More Show Less

For research use only and is not approved for use in humans or in clinical diagnosis

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.